Relapsed/Refractory Chronic Lymphocytic Leukemia: Chemoimmunotherapy, Treatment until Progression with Mechanism-Driven Agents or Finite-Duration Therapy?

Relapsed/Refractory Chronic Lymphocytic Leukemia: Chemoimmunotherapy, Treatment until Progression with Mechanism-Driven Agents or Finite-Duration Therapy? — المؤلف: Cuneo, Antonio — Mediterranean journal of hematology and infectious diseases 2019

المؤلف
Cuneo, Antonio
النشر
Mediterranean journal of hematology and infectious diseases 2019
الوصف
e2019024 p.